DE2413966A1 - Oxamidsaeure-derivate - Google Patents

Oxamidsaeure-derivate

Info

Publication number
DE2413966A1
DE2413966A1 DE2413966A DE2413966A DE2413966A1 DE 2413966 A1 DE2413966 A1 DE 2413966A1 DE 2413966 A DE2413966 A DE 2413966A DE 2413966 A DE2413966 A DE 2413966A DE 2413966 A1 DE2413966 A1 DE 2413966A1
Authority
DE
Germany
Prior art keywords
lower alkoxy
pyridyl
acid
nitro
ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE2413966A
Other languages
German (de)
English (en)
Inventor
Albert John Begany
Charles John Guinosso
John Hamilton Sellstedt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of DE2413966A1 publication Critical patent/DE2413966A1/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
    • C07C245/02—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides
    • C07C245/06—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings
    • C07C245/08—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings with the two nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings, e.g. azobenzene
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DE2413966A 1973-03-23 1974-03-22 Oxamidsaeure-derivate Ceased DE2413966A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34446673A 1973-03-23 1973-03-23

Publications (1)

Publication Number Publication Date
DE2413966A1 true DE2413966A1 (de) 1974-09-26

Family

ID=23350656

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2413966A Ceased DE2413966A1 (de) 1973-03-23 1974-03-22 Oxamidsaeure-derivate

Country Status (14)

Country Link
JP (1) JPS5920664B2 (ja)
AR (1) AR207563A1 (ja)
BE (1) BE812743A (ja)
CA (1) CA1034118A (ja)
CH (1) CH612914A5 (ja)
DE (1) DE2413966A1 (ja)
EG (1) EG11281A (ja)
ES (1) ES424514A1 (ja)
FI (1) FI61688C (ja)
FR (1) FR2222097B1 (ja)
NL (1) NL7403843A (ja)
PH (1) PH14870A (ja)
SE (1) SE411898B (ja)
ZA (1) ZA74635B (ja)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2627784A1 (de) * 1975-07-07 1977-01-27 Upjohn Co Oxalsaeureamidderivate und diese enthaltende arzneimittel
US4407810A (en) 1980-07-19 1983-10-04 Basf Aktiengesellschaft Thiazol-2-yl-oxamic acid derivatives, and therapeutic agents containing these compounds
EP0044443B1 (de) * 1980-07-19 1984-02-01 BASF Aktiengesellschaft Cycloalkano-thiazolyloxamidsäure-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende therapeutische Mittel
US4517196A (en) * 1981-09-05 1985-05-14 Basf Aktiengesellschaft Tricyclic thiazolyloxamic acids and their derivatives, their preparation, and therapeutic agents containing these compounds
WO1999046236A1 (en) * 1998-03-12 1999-09-16 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (ptpases)
US6225329B1 (en) 1998-03-12 2001-05-01 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (PTPases)
EP2033688A2 (de) 2007-08-20 2009-03-11 Symrise GmbH & Co. KG Oxalsäurederivate und deren Verwendung als physiologische Kühlwirkstoffe

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172147A (en) * 1976-11-17 1979-10-23 The Upjohn Company 3,5-Dinitro oxanilic acid ester compounds, compositions and methods
US4119783A (en) * 1977-02-18 1978-10-10 The Upjohn Company 3'Lower alkylcarbonyl oxanilic acid esters
NL7810634A (nl) * 1977-10-28 1979-05-02 May & Baker Ltd Tetrazool-derivaten.
FR2546885B1 (fr) * 1983-06-06 1986-02-07 Fabre Sa Pierre Oxamates d'anthranilates fonctionnalises utiles comme medicaments dans le traitement des dermatoses inflammatoires
JPS6112268U (ja) * 1984-06-25 1986-01-24 松下電工株式会社 プリント配線基板
JPH072697B2 (ja) * 1985-05-24 1995-01-18 久光製薬株式会社 新規なオキサニル酸誘導体

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2627784A1 (de) * 1975-07-07 1977-01-27 Upjohn Co Oxalsaeureamidderivate und diese enthaltende arzneimittel
US4407810A (en) 1980-07-19 1983-10-04 Basf Aktiengesellschaft Thiazol-2-yl-oxamic acid derivatives, and therapeutic agents containing these compounds
EP0044443B1 (de) * 1980-07-19 1984-02-01 BASF Aktiengesellschaft Cycloalkano-thiazolyloxamidsäure-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende therapeutische Mittel
US4517196A (en) * 1981-09-05 1985-05-14 Basf Aktiengesellschaft Tricyclic thiazolyloxamic acids and their derivatives, their preparation, and therapeutic agents containing these compounds
WO1999046236A1 (en) * 1998-03-12 1999-09-16 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (ptpases)
US6225329B1 (en) 1998-03-12 2001-05-01 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (PTPases)
EP2033688A2 (de) 2007-08-20 2009-03-11 Symrise GmbH & Co. KG Oxalsäurederivate und deren Verwendung als physiologische Kühlwirkstoffe
US8344025B2 (en) 2007-08-20 2013-01-01 Symrise Ag Oxalic acid derivatives and use thereof as physiological cooling active ingredients

Also Published As

Publication number Publication date
ZA74635B (en) 1975-09-24
BE812743A (fr) 1974-09-23
FR2222097A1 (ja) 1974-10-18
AU6575374A (en) 1975-08-21
FR2222097B1 (ja) 1978-06-30
ES424514A1 (es) 1976-06-16
NL7403843A (ja) 1974-09-25
SE411898B (sv) 1980-02-11
AR207563A1 (es) 1976-10-15
EG11281A (en) 1977-05-31
PH14870A (en) 1982-01-08
CH612914A5 (en) 1979-08-31
FI61688B (fi) 1982-05-31
CA1034118A (en) 1978-07-04
JPS5920664B2 (ja) 1984-05-15
FI61688C (fi) 1982-09-10
JPS49135929A (ja) 1974-12-27

Similar Documents

Publication Publication Date Title
DE2402398B2 (de) Aromatische Carbonsäureamid-Derivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen
DE2413966A1 (de) Oxamidsaeure-derivate
DE3249054T1 (de) (1-(2-benzoxazolyl)-hydrazino)-alkylnitril-derivate
DE2712079C3 (de) N-(5-Tetrazolyl)-4-oxo-4H-pyrimido[2,1-b]benzothiazol-3-carboxamide und ihre Verwendung zur Bekämpfung von allergischen Reaktionen
DE2012138C3 (de) N{4-(ß-Pyrazin- 2-carboxyamido-äthyl)benzolsulphonyl] -N' - cycloalkylharnstoffe und diese enthaltende pharmazeutische Präparate
DE2003841B2 (de) Virucide und immunsuppressive mittel
DE2363348C3 (de) Substituierte 5 (6)-Phenoxy-benzimidazol-2-carbaminsäuremethylester, deren Herstellung und diese enthaltende Anthelminthika
DE1670935A1 (de) Verfahren zur Herstellung von 2-Methyl-3-carbonsaeureamido-chinoxalin-di-N-oxiden-(1,4)
CH645354A5 (de) Chinolyl-guanidine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mischungen.
DE2824341A1 (de) N- eckige klammer auf 6- eckige klammer auf (aminosulfonyl)phenyl eckige klammer zu -1,2-dihydro-2-oxonicotinyl eckige klammer zu penicilline und -cephalosporine
DE3216843C2 (de) 3-Thiomethyl-pyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2804949A1 (de) Substituierte tetrazolverbindungen
DE2828261A1 (de) Neue penicilline, ihre salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3882785T2 (de) Di-t-butylphenylalkyl- und benzyläther.
DE3879378T2 (de) Amid-verbindungen.
DE2641291C2 (de) 2-cyano-3- oder 4-(substituiertes amino)-oxanilsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE2533843C2 (de) 2H-Pyran-2,6(3H)-dionderivate und deren Verwendung
DE2649855C2 (de) Substituierte 5-Acetyl-4-hydroxy-3-phenylamino-2H-pyran-2,6(3H)-dione, Verfahren zu deren Herstellung und deren Verwendung
DE2802508A1 (de) Tetrazole, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
DE2022746A1 (de) Blutzuckersenkende Sulfonylaminopyrimidine und Verfahren zu deren Herstellung
DE2624856A1 (de) 2-thiohexahydropyrimidin-4,6-dion-derivate und verfahren zu ihrer herstellung
DE2727207C2 (de) Substituierte 2H-Pyran-2,6(3H)-dion-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1445505C3 (de) Im Phenylkern substituierte 2-Phenylamino-13-diazacyclopentene-(2)
DE3121137A1 (de) Neue pyridazino(4,5-b)indole, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen, zwischenprodukte und deren herstellung"
DE2205194A1 (de) Neue Derivate des 2-Amino-3-hydroxypyridins

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8131 Rejection